processing...

Choose a analysis:

Hint: You can either select all, or use ctrl + select to choose multiple

Check the experimental factors of this study in the table below. The first column is grouped (combined) factors and subsequent columns are individual factors

sample_sourcecombined_factorsGenotypeTreatmentMetaboliteTissue
1PlasmaGenotype:F344 Pirc | Treatment:200 ppm Naproxen | Metabolite:Eicosanoid | Tissue:PlasmaF344 Pirc200 ppm NaproxenEicosanoidPlasma
2Tumor-adjacent normal colonGenotype:F344 Pirc | Treatment:200 ppm Naproxen | Metabolite:Eicosanoid | Tissue:Tumor-adjacent normal colonF344 Pirc200 ppm NaproxenEicosanoidTumor-adjacent normal colon
3PlasmaGenotype:F344 Pirc | Treatment:200 ppm Naproxen | Metabolite:Fatty Acid | Tissue:PlasmaF344 Pirc200 ppm NaproxenFatty AcidPlasma
4Tumor-adjacent normal colonGenotype:F344 Pirc | Treatment:200 ppm Naproxen | Metabolite:Fatty Acid | Tissue:Tumor-adjacent normal colonF344 Pirc200 ppm NaproxenFatty AcidTumor-adjacent normal colon
5PlasmaGenotype:F344 Pirc | Treatment:AIN-93G (control) | Metabolite:Eicosanoid | Tissue:PlasmaF344 PircAIN-93G (control)EicosanoidPlasma
6Tumor-adjacent normal colonGenotype:F344 Pirc | Treatment:AIN-93G (control) | Metabolite:Eicosanoid | Tissue:Tumor-adjacent normal colonF344 PircAIN-93G (control)EicosanoidTumor-adjacent normal colon
7PlasmaGenotype:F344 Pirc | Treatment:AIN-93G (control) | Metabolite:Fatty Acid | Tissue:PlasmaF344 PircAIN-93G (control)Fatty AcidPlasma
8Tumor-adjacent normal colonGenotype:F344 Pirc | Treatment:AIN-93G (control) | Metabolite:Fatty Acid | Tissue:Tumor-adjacent normal colonF344 PircAIN-93G (control)Fatty AcidTumor-adjacent normal colon
9PlasmaGenotype:F344 Pirc | Treatment:EPA-FFA (2%) + 200 ppm Naproxen | Metabolite:Eicosanoid | Tissue:PlasmaF344 PircEPA-FFA (2%) + 200 ppm NaproxenEicosanoidPlasma
10Tumor-adjacent normal colonGenotype:F344 Pirc | Treatment:EPA-FFA (2%) + 200 ppm Naproxen | Metabolite:Eicosanoid | Tissue:Tumor-adjacent normal colonF344 PircEPA-FFA (2%) + 200 ppm NaproxenEicosanoidTumor-adjacent normal colon
11PlasmaGenotype:F344 Pirc | Treatment:EPA-FFA (2%) + 200 ppm Naproxen | Metabolite:Fatty Acid | Tissue:PlasmaF344 PircEPA-FFA (2%) + 200 ppm NaproxenFatty AcidPlasma
12Tumor-adjacent normal colonGenotype:F344 Pirc | Treatment:EPA-FFA (2%) + 200 ppm Naproxen | Metabolite:Fatty Acid | Tissue:Tumor-adjacent normal colonF344 PircEPA-FFA (2%) + 200 ppm NaproxenFatty AcidTumor-adjacent normal colon
13PlasmaGenotype:F344 Pirc | Treatment:EPA-FFA (2% EPA) | Metabolite:Eicosanoid | Tissue:PlasmaF344 PircEPA-FFA (2% EPA)EicosanoidPlasma
14Tumor-adjacent normal colonGenotype:F344 Pirc | Treatment:EPA-FFA (2% EPA) | Metabolite:Eicosanoid | Tissue:Tumor-adjacent normal colonF344 PircEPA-FFA (2% EPA)EicosanoidTumor-adjacent normal colon
15PlasmaGenotype:F344 Pirc | Treatment:EPA-FFA (2% EPA) | Metabolite:Fatty Acid | Tissue:PlasmaF344 PircEPA-FFA (2% EPA)Fatty AcidPlasma
16Tumor-adjacent normal colonGenotype:F344 Pirc | Treatment:EPA-FFA (2% EPA) | Metabolite:Fatty Acid | Tissue:Tumor-adjacent normal colonF344 PircEPA-FFA (2% EPA)Fatty AcidTumor-adjacent normal colon
17PlasmaGenotype:F344 Pirc | Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen | Metabolite:Eicosanoid | Tissue:PlasmaF344 PircHD TP-252 (3% EPA) + 200 ppm NaproxenEicosanoidPlasma
18Tumor-adjacent normal colonGenotype:F344 Pirc | Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen | Metabolite:Eicosanoid | Tissue:Tumor-adjacent normal colonF344 PircHD TP-252 (3% EPA) + 200 ppm NaproxenEicosanoidTumor-adjacent normal colon
19PlasmaGenotype:F344 Pirc | Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen | Metabolite:Fatty Acid | Tissue:PlasmaF344 PircHD TP-252 (3% EPA) + 200 ppm NaproxenFatty AcidPlasma
20Tumor-adjacent normal colonGenotype:F344 Pirc | Treatment:HD TP-252 (3% EPA) + 200 ppm Naproxen | Metabolite:Fatty Acid | Tissue:Tumor-adjacent normal colonF344 PircHD TP-252 (3% EPA) + 200 ppm NaproxenFatty AcidTumor-adjacent normal colon
21PlasmaGenotype:F344 Pirc | Treatment:HD TP-252 (3% EPA) | Metabolite:Eicosanoid | Tissue:PlasmaF344 PircHD TP-252 (3% EPA)EicosanoidPlasma
22Tumor-adjacent normal colonGenotype:F344 Pirc | Treatment:HD TP-252 (3% EPA) | Metabolite:Eicosanoid | Tissue:Tumor-adjacent normal colonF344 PircHD TP-252 (3% EPA)EicosanoidTumor-adjacent normal colon
23PlasmaGenotype:F344 Pirc | Treatment:HD TP-252 (3% EPA) | Metabolite:Fatty Acid | Tissue:PlasmaF344 PircHD TP-252 (3% EPA)Fatty AcidPlasma
24Tumor-adjacent normal colonGenotype:F344 Pirc | Treatment:HD TP-252 (3% EPA) | Metabolite:Fatty Acid | Tissue:Tumor-adjacent normal colonF344 PircHD TP-252 (3% EPA)Fatty AcidTumor-adjacent normal colon
25PlasmaGenotype:F344 Pirc | Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Metabolite:Eicosanoid | Tissue:PlasmaF344 PircLD TP-252 (1.5% EPA) + 200 ppm NaproxenEicosanoidPlasma
26Tumor-adjacent normal colonGenotype:F344 Pirc | Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Metabolite:Eicosanoid | Tissue:Tumor-adjacent normal colonF344 PircLD TP-252 (1.5% EPA) + 200 ppm NaproxenEicosanoidTumor-adjacent normal colon
27PlasmaGenotype:F344 Pirc | Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Metabolite:Fatty Acid | Tissue:PlasmaF344 PircLD TP-252 (1.5% EPA) + 200 ppm NaproxenFatty AcidPlasma
28Tumor-adjacent normal colonGenotype:F344 Pirc | Treatment:LD TP-252 (1.5% EPA) + 200 ppm Naproxen | Metabolite:Fatty Acid | Tissue:Tumor-adjacent normal colonF344 PircLD TP-252 (1.5% EPA) + 200 ppm NaproxenFatty AcidTumor-adjacent normal colon
29PlasmaGenotype:F344 Pirc | Treatment:LD TP-252 (1.5% EPA) | Metabolite:Eicosanoid | Tissue:PlasmaF344 PircLD TP-252 (1.5% EPA)EicosanoidPlasma
30Tumor-adjacent normal colonGenotype:F344 Pirc | Treatment:LD TP-252 (1.5% EPA) | Metabolite:Eicosanoid | Tissue:Tumor-adjacent normal colonF344 PircLD TP-252 (1.5% EPA)EicosanoidTumor-adjacent normal colon
31PlasmaGenotype:F344 Pirc | Treatment:LD TP-252 (1.5% EPA) | Metabolite:Fatty Acid | Tissue:PlasmaF344 PircLD TP-252 (1.5% EPA)Fatty AcidPlasma
32Tumor-adjacent normal colonGenotype:F344 Pirc | Treatment:LD TP-252 (1.5% EPA) | Metabolite:Fatty Acid | Tissue:Tumor-adjacent normal colonF344 PircLD TP-252 (1.5% EPA)Fatty AcidTumor-adjacent normal colon

Choose factor column:

Take a hint from the table above




  logo